Tiemann Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Tiemann Investment Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Hold	2,500	–	–	0.08%	180
2026 Q1	$200K	Sell	2,500 -50	-2%	-$4.12K	0.08%	188
2025 Q4	$217K	Buy	+2,550	New	+$209K	0.08%	178
2024 Q3	–	Sell	-2,325	Closed	-$215K	–	199
2024 Q2	$215K	Hold	2,325	–	–	0.1%	173
2024 Q1	$222K	Buy	+2,325	New	+$195K	0.1%	178
2023 Q3	–	Sell	-2,125	Closed	-$200K	–	185
2023 Q2	$200K	Buy	+2,125	New	+$185K	0.1%	189
2022 Q3	–	Sell	-2,025	Closed	-$193K	–	187
2022 Q2	$193K	Buy	2,025 +50	+3%	+$5.18K	0.1%	186
2022 Q1	$232K	Hold	1,975	–	–	0.11%	183
2021 Q4	$256K	Hold	1,975	–	–	0.11%	181
2021 Q3	$224K	Sell	1,975 -220	-10%	-$25.1K	0.11%	188
2021 Q2	$227K	Buy	+2,195	New	+$207K	0.11%	193
2021 Q1	–	Sell	-2,315	Closed	-$211K	–	208
2020 Q4	$211K	Sell	2,315 -250	-10%	-$20.7K	0.11%	191
2020 Q3	$205K	Buy	+2,565	New	+$200K	0.13%	174

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Tiemann Investment Advisors's EW Position: Q2 2026 in Review

Tiemann Investment Advisors held its Edwards Lifesciences (EW) position steady in Q2 2026 at 2,500 shares worth $226K. The position accounts for 0.08% of the portfolio, ranked #180.

Tiemann Investment Advisors first reported a position in EW in Q3 2020 and has held it in 13 quarters since. The position peaked at $256K in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Tiemann Investment Advisors held 2,500 shares of Edwards Lifesciences worth $226K as of Q2 2026.
Tiemann Investment Advisors left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.08% of Tiemann Investment Advisors's portfolio in Q2 2026, its #180 holding.
Tiemann Investment Advisors first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 13 quarters since.
Tiemann Investment Advisors's Edwards Lifesciences position peaked at $256K in Q4 2021.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Tiemann Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.